Portola Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 10,531 72,042 78,029
Cost of Revenue - - -
Gross Profit 10,531 72,042 78,029
Operating Expenses
Research and Development 79,286 49,717 46,089
Sales, General and Admin. 15,423 11,469 12,071
Non-Recurring Items - - -
Other - - -
Operating Income (84,178) 10,856 19,869
Income From Continuing Operations
Add'l Income/Expense Items 826 510 136
Earnings Before Interest and Tax (83,352) 11,366 20,005
Interest Expense - - 21
Earnings Before Tax (83,352) 11,366 19,984
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (83,352) 11,366 19,984
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (83,352) 11,366 19,984
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (83,352) 11,366 19,984